THE CHROMOSOME | Clinical Content Series
Hyperinsulinaemia
Back to Case Studies ArchiveCase Study
She was 34 years old and had never been told what was wrong with her. That was precisely how she described it, nobody had ever told her what was actually wrong. She had been overweight since her early twenties. She had tried every dietary approach available, low calorie, low fat, low carbohydrate, intermittent fasting, meal replacement. Each had produced some initial weight loss. Each had eventually stopped working, often within weeks, sometimes within days. The weight had always returned, and with each cycle of loss and regain it had settled slightly higher than before, as though her body was learning from each attempt and building its defences accordingly.
She was not wrong. Her body was learning. But it was not learning from the diets. It was responding to insulin, and insulin had been running at pathological levels in her bloodstream for over a decade without anyone ever measuring it.
Her fasting glucose when she arrived was 94 milligrams per decilitre. Perfectly normal. Her HbA1c was 5.2 percent. Perfectly normal. By every standard metabolic measure that Pakistani physicians routinely assess, her glucose metabolism was completely unremarkable. And yet she had gained 27 kilograms across twelve years of determined effort to prevent exactly that.
I ordered a fasting insulin. It was 47 microunits per millilitre. The upper limit of normal is 25. Hers was nearly double, chronically, persistently, silently, while every glucose measurement her previous physicians had taken had reassured them that her metabolism was fine.
This is hyperinsulinaemia. Elevated insulin with normal glucose. The condition that exists before insulin resistance becomes severe enough to elevate blood sugar. The condition that drives fat storage, prevents fat release, generates hunger, promotes visceral fat accumulation, suppresses growth hormone, disrupts sex hormones, and systematically dismantles metabolic health across years and decades, while every standard blood test returns normal and every physician tells the patient that nothing is wrong.
Nothing is wrong on the tests they are ordering. Everything is wrong on the test they are not.
Hyperinsulinaemia is, in my clinical experience, the most common undiagnosed primary driver of obesity in Pakistani patients. I say primary driver because in many cases the elevated insulin precedes and produces the obesity, it is not a consequence of weight gain but its cause. A Pakistani patient who begins producing excess insulin in response to a dietary pattern that chronically overstimulates insulin secretion, or whose genetic predisposition to insulin hypersecretion is present from early adulthood, will gain weight progressively and reliably regardless of caloric intake, because the insulin environment their body is living in directs every metabolic process toward fat storage and away from fat utilisation.
The FTO gene's influence on pancreatic beta cell secretory function in Pakistani patients creates exactly this predisposition. The FTO associated metabolic profile in Pakistanis is characterised by an exaggerated insulin secretory response to carbohydrate ingestion, the beta cells fire more insulin than the glucose stimulus warrants, producing postprandial insulin spikes that drive fat storage, generate reactive hypoglycaemia, stimulate further hunger, and sustain the cycle of eating, insulin spiking, and fat deposition that produces progressive weight gain in the absence of any measurable glucose abnormality.
This patient had been on a dietary treadmill for twelve years because every dietary intervention she had attempted had been designed to reduce calories rather than to reduce insulin. Reducing calories in a hyperinsulinaemic patient produces temporary weight loss through caloric deficit, but as long as insulin remains elevated, the fat storage signal persists, the hunger signal persists, and the metabolic machinery remains oriented toward accumulation rather than utilisation. The moment caloric restriction is relaxed, even slightly, the elevated insulin reasserts its authority and the weight returns.
We redesigned her entire metabolic environment around insulin reduction rather than caloric reduction. We restructured her dietary pattern specifically to minimise insulin secretory stimulus. We addressed the visceral fat that had accumulated and was amplifying her insulin resistance. We recalibrated her cortisol, which had been contributing to overnight insulin elevation through its effect on hepatic glucose output. We deployed targeted interventions to reduce pancreatic beta cell hypersecretion and restore appropriate insulin pulsatility.
Eleven months later she had lost 22 kilograms. Her fasting insulin was 18, within the normal range for the first time in over a decade. She had not counted a single calorie.
She had not been failing at weight loss for twelve years. She had been attempting weight loss with the wrong tool for twelve years. The right tool was always insulin. Nobody had thought to measure it.
FAQs
Hyperinsulinaemia is a state of chronically elevated insulin in the bloodstream, occurring in the presence of normal blood glucose levels, before insulin resistance has become severe enough to impair glucose control. Because Pakistani physicians assess glucose and HbA1c rather than insulin, hyperinsulinaemia is invisible to standard metabolic panels, the patient appears metabolically normal while their insulin is driving progressive fat storage, hunger amplification, and hormonal disruption silently. Dr. Zaar identifies hyperinsulinaemia as the most common undiagnosed primary driver of obesity in Pakistani patients, present in a substantial proportion of those who have failed every conventional weight loss approach while being told their metabolism is normal.
Insulin is the master regulator of fat storage and fat release. At elevated levels it activates fat storage enzymes in adipose tissue, directing glucose and fatty acids into fat cells for storage. Simultaneously it suppresses hormone sensitive lipase, the enzyme responsible for releasing stored fat for energy, making fat mobilisation biologically impossible regardless of caloric deficit. A hyperinsulinaemic patient eating at a caloric deficit is still storing fat because the insulin signal overrides the caloric mathematics. This is why calorie restricted diets produce only temporary results in hyperinsulinaemic Pakistani patients, the weight lost during restriction returns the moment normal eating resumes because the insulin environment that drove the original accumulation has never changed.
The FTO gene at Chromosome 16q12.2 influences pancreatic beta cell secretory behaviour, the mechanism by which the pancreas calibrates its insulin output in response to dietary glucose. In Pakistani patients, the FTO associated metabolic profile produces an exaggerated insulin secretory response to carbohydrate ingestion, the beta cells release more insulin than the glucose stimulus warrants, generating postprandial insulin spikes that drive fat storage, reactive hunger, and progressive visceral fat accumulation. This hypersecretory predisposition is present from early adulthood and is activated and amplified by the refined carbohydrate dietary patterns of Pakistani urban life, creating a hyperinsulinaemic state that operates for years before any glucose abnormality appears on standard testing.
Hyperinsulinaemia disrupts satiety signalling through multiple simultaneous mechanisms. Elevated insulin drives postprandial reactive hypoglycaemia, the blood glucose falls rapidly after meals in response to the insulin spike, triggering hunger signals within one to two hours of eating regardless of the quantity consumed. High insulin suppresses leptin sensitivity in the hypothalamus, reducing the brain's ability to register satiety from existing fat stores. It elevates ghrelin, the hunger hormone, independently of actual energy availability. And it impairs the gut hormone responses that normally signal meal completion to the brain. The hyperinsulinaemic Pakistani patient is not hungry because they lack self control. They are hungry because their hormonal environment has disconnected the relationship between food intake and satiety signalling.
Chronically elevated insulin disrupts hormonal health across every axis simultaneously. It drives androgen excess in Pakistani women, stimulating ovarian testosterone production and promoting PCOS. It suppresses sex hormone binding globulin, increasing the biological activity of androgens and oestrogens in ways that amplify hormonal imbalance. It suppresses growth hormone pulsatility, impairing the anabolic hormonal environment required for muscle maintenance and fat oxidation. It promotes cortisol dysregulation by increasing the metabolic demand on the stress response system. And it drives the progressive inflammatory state that suppresses thyroid conversion and impairs every downstream hormonal process. Hyperinsulinaemia is not merely a metabolic problem. It is a hormonal catastrophe operating in slow motion, and in Pakistani patients it frequently begins a decade before any conventional test detects it.
Reducing hyperinsulinaemia requires restructuring the dietary pattern around insulin secretory stimulus rather than caloric content. The primary drivers of insulin hypersecretion in Pakistani patients are refined carbohydrates, white rice, white bread, refined flour products, and sugar, which produce rapid and exaggerated postprandial insulin spikes in individuals with FTO associated beta cell hypersecretory predisposition. Reducing these foods while increasing dietary protein, healthy fats, and low glycaemic carbohydrates reduces the insulin secretory demand without requiring caloric restriction. Meal timing and frequency also matter significantly, frequent small meals maintain continuous insulin elevation while strategic meal spacing allows insulin to fall between eating episodes. Dr. Zaar designs dietary protocols specifically around insulin reduction rather than caloric mathematics, because in hyperinsulinaemic Pakistani patients the insulin is the target, not the calorie.
Chronically elevated insulin accelerates cellular ageing through several well documented mechanisms. It activates the mTOR pathway, a cellular growth and metabolism regulator that when chronically stimulated promotes cellular senescence and suppresses the autophagy through which cells clear damaged components. It promotes advanced glycation end products, sugar protein complexes that accumulate in tissues and impair organ function progressively. It sustains the systemic inflammatory state that underlies accelerated vascular ageing, cognitive decline, and immune deterioration. And it suppresses the growth hormone and IGF-1 axis in ways that reduce the anabolic repair capacity of every tissue in the body. Pakistani patients with long standing hyperinsulinaemia age metabolically faster than their chronological age, presenting with the biological profile of someone a decade older in terms of vascular health, hormonal function, and inflammatory burden.
THE CHROMOSOME protocol addresses hyperinsulinaemia through a coordinated intervention targeting every driver of insulin hypersecretion simultaneously. Dietary recalibration eliminates the refined carbohydrate substrate driving exaggerated postprandial insulin spikes. Visceral fat reduction removes the inflammatory amplification of insulin resistance that sustains compensatory hyperinsulinaemia. Cortisol recalibration eliminates the overnight hepatic glucose output that maintains fasting insulin elevation. Targeted peptide based interventions support pancreatic beta cell function restoration and reduce hypersecretory behaviour at the cellular level. Sleep architecture restoration reduces the nocturnal insulin dysregulation driven by growth hormone suppression and cortisol elevation. Every component of the protocol is designed to reduce insulin, because in hyperinsulinaemic Pakistani patients, reducing insulin is the single intervention from which every other metabolic improvement follows.